Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × inavolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 1 PIK3CA-Mutated Cancers 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Doxorubicin 20 Radiotherapy 19 olaparib 16 lenvatinib 16 Taxes 16 Megestrol Acetate 16 Docetaxel 15 dostarlimab 14 Specimen Handling 14 Nivolumab 14 Metformin 13 Magnetic Resonance Spectroscopy 12 durvalumab 11 Fulvestrant 11 temsirolimus 10 Medroxyprogesterone Acetate 10 Indocyanine Green 10 abemaciclib 9 Trastuzumab 9 Radiation 9 Gemcitabine 9 Brachytherapy 9 Biopsy 9 Observation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2025-09-04

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡